LCN2 and prostate carcinoma: Other genes act as tumor suppressors, such as IGFBP3, which inhibits prostate cancer growth through suppression of angiogenesis [35], and LCN2, which increases the expression of E-cadherin and suppresses cell invasiveness [36].